José Alberto Ayala Ortiz selected as one of the top ten CEOs of 2023

Post published:August 22, 2023

We are very glad to announce that José Alberto Ayala Ortiz has been selected as one of the top ten CEOs of 2023. Industry Tech Outlook has chosen José, a full article has been issued at the magazine website, it can be found here: https://industry-techoutlook.com/magazine/Top-10-CEOs-Of-2023/ Being the CEO of PVpharm, José is a visionary and inspirational leader. He sets a clear direction for the organization's future while motivating and uniting the organization. José’s leadership drives growth, innovation, and success, creating a positive work environment, attracting top talent, and building solid stakeholder relationships. The company has been growing in business since…

Meet us in September! at Farmaforum (Madrid) and BIOSPAIN (Barcelona)

Post published:August 18, 2023

PVpharm is going to participate in the next events of the pharmaceutical and biotechnology industry in Spain. Farmaforum will be held in Madrid from September 19 to 20, and BIOSPAIN will be held in Barcelona from September 26 to 28. Come visit us and let's talk about pharmacovigilance services, safety in clinical trials, audits, quality and many other topics related to drug development. We are looking forward to seeing you!

IV PV TRAINING: unique pharmacovigilance training experience

Post published:July 11, 2023

PVpharm led the way in pharmacovigilance training by innovatively organizing another edition of its Pharmacovigilance Training. This 3rd edition was hosted on May, 2022.

PVpharm starts a new collaboration with the International AIDS Vaccine Initiative (IAVI)

Post published:May 22, 2023

We are so excited to announce the new collaboration agreement signed by our company with the International AIDS Vaccine Initiative (IAVI) to provide pharmacovigilance and regulatory consulting. IAVI is a nonprofit scientific research organization that develops vaccines and antibodies for HIV, tuberculosis, emerging infectious diseases (including COVID-19), and other neglected diseases, with a clear commitment to develop affordable and accesible solutions to these diseases. In the same way as our collaboration with the Leiden University Medical Center (LUMC) or with the Center for Human Drug Research (CHDR), PVpharm works to provide pharmacovigilance support in pre-approval phases of the development of innovative drugs. In this agreement, we…

We are in the press! El Economista

Post published:May 9, 2023

PVpharm is in "El Economista" on 9th May 2023, the news diary published an article about PVpharm; where our CEO, José Alberto Ayala Ortiz, introduces our company, explains what pharmacovigilance is and how does PVpharm deal with different regulations. PVpharm is a global reference in Pharmacovigilance: https://www.eleconomista.es/branded-content/noticias/12258631/05/23/jose-alberto-ayala-ortiz-pvpharm-somos-una-referencia-global-en-el-campo-de-la-farmacovigilancia.html You can follow us on LinkedIn and learn more about us clicking here.

Round table and discussion – Differences between Phase III and Phase IV Drug Safety and Pharmacovigilance – University of Valladolid

Post published:November 12, 2022

José Alberto Ayala Ortiz, PVpharm CEO, will participate together with Andrea Álvarez, QPPV of FAES FARMA in a Round table and discussion about "Differences between Phase III and Phase IV Drug Safety and Pharmacovigilance" organized by the University of Valladolid. The conference will be held on 17th November 2022 at 18:00 CET, and it is free of access!! Please join here. https://forms.gle/FEDtVzLfZJfBxq448?fbclid=IwAR1eQx0ISwSau6DZmHZ-ZszE4-QJPcMpfm9wuXa2pMCinMTg0U8LGmTnQNo PVpharm is also organizing in-house trainings in pharmacovigilance for pharmaceutical companies and CROs, please contact us for further information.

PVpharm participates in the 2022 European Researchers’ Night

Post published:September 29, 2022

The European Researchers' Night is a Europe-wide public event, which displays the diversity of science and its impact on citizens' daily lives in fun, inspiring ways. This year, the event will take place in 25 countries on Friday 30 September 2022. The European Researchers' Night aims to: -bring research and researchers closer to the public-promote excellent research projects across Europe and beyond-increase the interest of young people in science and research careers-showcase the impact of researchers’ work on people’s daily lives The European Researchers’ Night attracts each year more than 1 million visitors in Europe and beyond. Juego de la…

Meet us at Farmaforum 4-5 October 2022!

Post published:September 29, 2022

PVpharm will participate as an exhibitor in the next edition of Farmaforum, one of the most important events of the Pharmaceutical Industry in Spain. The event will be held in Madrid at IFEMA on the 4th and 5th of October 2022. We are so excited and impatiently anticipating the day of the event. If you decide to visit us, we will be so happy to receive you at our stand, STAND B70, to provide you any kind of information regarding our company, services, careers, etc; or to just have a cup of coffee and share a nice talk. José Alberto Ayala Ortiz, CEO…

PVpharm team Arrecife de las Sirenas 2022

PVpharm team summer offsite meeting in Almeria 2022

Post published:September 8, 2022

The PVpharm team had a meeting in Almería on the 29th and 30th of August 2022. The team did several activities, including a hiking route from Arrecife de las Sirenas to Cala Rajá, in the Natural Park of Cabo de Gata. The route was coached by AGata Verde, an innovative project in the field of Environmental Education, aimed at providing tools for learning care and respect for the environment. We stopped for a swim in Cala Rajá. Afterwards there was a lunch and an swim and snorkeling in the beach of Las Salinas. On the next day the team had…

PVpharm to present a key trending subject at Farmaforum 2022

Post published:June 23, 2022

In the next edition (October 2022), PVpharm will not only participate as an exhibitor but also as a speaker, leading one of the conferences of this benchmark event.